| Dr Joseph Marshall Bowen, MD | |
|
1296 E Polston Ave, Suite B, Post Falls, ID 83854-5217 | |
| (208) 457-7075 | |
| (208) 457-7076 |
| Full Name | Dr Joseph Marshall Bowen |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 20 Years |
| Location | 1296 E Polston Ave, Post Falls, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003029034 | NPI | - | NPPES |
| 808321400 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | A95207 (California) | Secondary |
| 207X00000X | Orthopaedic Surgery | M-10494 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kootenai Health | Coeur d'alene, ID | Hospital |
| Shoshone Medical Center | Kellogg, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kootenai Health Inc | 1355792276 | 291 |
| Kootenai Health, Inc. | 4789641598 | 331 |
News Archive
Oregon Health & Science University today released an iPhone app designed to advance melanoma research by giving users the ability to accurately measure and monitor moles, and contribute photos of how their potential trouble spots evolve over time.
Patients who are likely to experience disease recurrence after undergoing hepatectomy for hepatocellular carcinoma can be identified by factors that are available preoperatively, indicate the results of a Hong Kong study.
Reinforcing its commitment to researchers and clinicians, GE Healthcare, a unit of General Electric Company is showcasing a comprehensive molecular imaging portfolio—encompassing tracer development, pre-clinical imaging and highly advanced imaging equipment— to provide insight into the origins of disease, at the World Molecular Imaging Congress (WMIC), Booth #212, September 8 through 11 in Kyoto, Japan.
Results from the combined analysis of two European Phase II trials were presented today at the 3rd European Lung Cancer Conference in Geneva, Switzerland. The VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer (NSCLC) patients treated with the combination therapy bevacizumab plus erlotinib.
Nearly 2,500 physicians and scientists from institutions around the world such as the World Health Organization, the Centers for Disease Control and the National Institutes of Health will meet at the 56th American Society of Tropical Medicine and Hygiene's Annual Meeting on Nov. 4-8, in Philadelphia to discuss the latest research on infectious diseases and bioterrorist and global health threats.
› Verified 1 days ago
| Entity Name | Kootenai Health, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235288655 PECOS PAC ID: 4789641598 Enrollment ID: O20041214000230 |
News Archive
Oregon Health & Science University today released an iPhone app designed to advance melanoma research by giving users the ability to accurately measure and monitor moles, and contribute photos of how their potential trouble spots evolve over time.
Patients who are likely to experience disease recurrence after undergoing hepatectomy for hepatocellular carcinoma can be identified by factors that are available preoperatively, indicate the results of a Hong Kong study.
Reinforcing its commitment to researchers and clinicians, GE Healthcare, a unit of General Electric Company is showcasing a comprehensive molecular imaging portfolio—encompassing tracer development, pre-clinical imaging and highly advanced imaging equipment— to provide insight into the origins of disease, at the World Molecular Imaging Congress (WMIC), Booth #212, September 8 through 11 in Kyoto, Japan.
Results from the combined analysis of two European Phase II trials were presented today at the 3rd European Lung Cancer Conference in Geneva, Switzerland. The VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer (NSCLC) patients treated with the combination therapy bevacizumab plus erlotinib.
Nearly 2,500 physicians and scientists from institutions around the world such as the World Health Organization, the Centers for Disease Control and the National Institutes of Health will meet at the 56th American Society of Tropical Medicine and Hygiene's Annual Meeting on Nov. 4-8, in Philadelphia to discuss the latest research on infectious diseases and bioterrorist and global health threats.
› Verified 1 days ago
| Entity Name | Kootenai Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174661151 PECOS PAC ID: 1355792276 Enrollment ID: O20240111003252 |
News Archive
Oregon Health & Science University today released an iPhone app designed to advance melanoma research by giving users the ability to accurately measure and monitor moles, and contribute photos of how their potential trouble spots evolve over time.
Patients who are likely to experience disease recurrence after undergoing hepatectomy for hepatocellular carcinoma can be identified by factors that are available preoperatively, indicate the results of a Hong Kong study.
Reinforcing its commitment to researchers and clinicians, GE Healthcare, a unit of General Electric Company is showcasing a comprehensive molecular imaging portfolio—encompassing tracer development, pre-clinical imaging and highly advanced imaging equipment— to provide insight into the origins of disease, at the World Molecular Imaging Congress (WMIC), Booth #212, September 8 through 11 in Kyoto, Japan.
Results from the combined analysis of two European Phase II trials were presented today at the 3rd European Lung Cancer Conference in Geneva, Switzerland. The VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer (NSCLC) patients treated with the combination therapy bevacizumab plus erlotinib.
Nearly 2,500 physicians and scientists from institutions around the world such as the World Health Organization, the Centers for Disease Control and the National Institutes of Health will meet at the 56th American Society of Tropical Medicine and Hygiene's Annual Meeting on Nov. 4-8, in Philadelphia to discuss the latest research on infectious diseases and bioterrorist and global health threats.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Marshall Bowen, MD 2003 Kootenai Health Way, Coeur D Alene, ID 83814-6051 Ph: (208) 625-4000 | Dr Joseph Marshall Bowen, MD 1296 E Polston Ave, Suite B, Post Falls, ID 83854-5217 Ph: (208) 457-7075 |
News Archive
Oregon Health & Science University today released an iPhone app designed to advance melanoma research by giving users the ability to accurately measure and monitor moles, and contribute photos of how their potential trouble spots evolve over time.
Patients who are likely to experience disease recurrence after undergoing hepatectomy for hepatocellular carcinoma can be identified by factors that are available preoperatively, indicate the results of a Hong Kong study.
Reinforcing its commitment to researchers and clinicians, GE Healthcare, a unit of General Electric Company is showcasing a comprehensive molecular imaging portfolio—encompassing tracer development, pre-clinical imaging and highly advanced imaging equipment— to provide insight into the origins of disease, at the World Molecular Imaging Congress (WMIC), Booth #212, September 8 through 11 in Kyoto, Japan.
Results from the combined analysis of two European Phase II trials were presented today at the 3rd European Lung Cancer Conference in Geneva, Switzerland. The VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer (NSCLC) patients treated with the combination therapy bevacizumab plus erlotinib.
Nearly 2,500 physicians and scientists from institutions around the world such as the World Health Organization, the Centers for Disease Control and the National Institutes of Health will meet at the 56th American Society of Tropical Medicine and Hygiene's Annual Meeting on Nov. 4-8, in Philadelphia to discuss the latest research on infectious diseases and bioterrorist and global health threats.
› Verified 1 days ago
Dr. Edward Michael Rooney, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1296 E Polston Ave Ste C, Post Falls, ID 83854 Phone: 208-625-6700 Fax: 208-625-6701 | |
Dr. Joanne Halbrecht, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3773 W 5th Ave, Post Falls, ID 83854 Phone: 208-758-8893 | |
Dr. Jonathan Jay Linthicum, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1296 E Polston Ave Ste C, Post Falls, ID 83854 Phone: 208-457-7075 | |
Dr. Christopher Bateman Dewing, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1610 E Schneidmiller Ave, Post Falls, ID 83854 Phone: 208-618-6070 Fax: 208-618-8903 | |
Dr. Roland Stanley Kent, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1641 E Polston Ave Ste 101, Post Falls, ID 83854 Phone: 208-457-4208 Fax: 208-457-4197 | |
Dr. David Michael Glassman, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1641 E Polston Ave Ste 101, Post Falls, ID 83854 Phone: 208-457-4208 Fax: 208-457-4197 |